Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

99mTc-labelled compounds prepared with sodium dithionite as reducing agent.

S Vilcek, M Kalincák, V Machán

    Nuklearmedizin. Nuclear Medicine
    |December 1, 1981
    PubMed
    Summary

    Sodium dithionite (Na2S2O4) effectively labels compounds with technetium-99m (99mTc) in neutral solutions. This method yielded high bone uptake for 99mTc-HEDSPA and 99mTc-MDP, and produced distinct kidney- or bone-targeting complexes with 99mTc-gluconate.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The surface modification of the silica-coated magnetic nanoparticles and their application in molecular diagnostics of virus infection.

    Scientific reports·2024
    Same author

    SARS-CoV-2: Zoonotic origin of pandemic coronavirus.

    Acta virologica·2020
    Same author

    Genetic variability of pig and human rotavirus group A isolates from Slovakia.

    Archives of virology·2019
    Same author

    Systemic immune response of gnotobiotic mice infected with porcine circovirus type 2 after administration of <i>Lactobacillus reuteri</i> L26 Biocenol™.

    Beneficial microbes·2018
    Same author

    Genetic variability of the S1 subunit of enteric and respiratory bovine coronavirus isolates.

    Acta virologica·2017
    Same author

    Influence of Lactobacillus reuteri L26 Biocenol™ on immune response against porcine circovirus type 2 infection in germ-free mice.

    Beneficial microbes·2017

    Area of Science:

    • Radiochemistry
    • Nuclear Medicine
    • Inorganic Chemistry

    Background:

    • Technetium-99m (99mTc) radiopharmaceuticals are crucial for diagnostic imaging.
    • Efficient and reliable methods for labeling biomolecules with 99mTc are essential.
    • Sodium dithionite (Na2S2O4) is a potent reducing agent with potential applications in radiolabeling.

    Purpose of the Study:

    • To investigate the efficacy of sodium dithionite (Na2S2O4) as a reducing agent for preparing 99mTc-labeled compounds.
    • To evaluate the biodistribution of novel 99mTc-labeled compounds, including those targeting bone and kidney.
    • To characterize the technetium complexes formed during the labeling process.

    Main Methods:

    • Reduction of pertechnetate using Na2S2O4 in neutral solutions (pH 7).

    Related Experiment Videos

  • Labeling of various compounds including DTPA, HEDSPA, MDP, gluconate, citrate, and trypsin with 99mTc.
  • Biodistribution studies in rats to assess the accumulation of 99mTc in different organs and tissues.
  • Characterization of the technetium complexes formed, including oxidation state and binding mode.
  • Main Results:

    • Successful labeling of DTPA, HEDSPA, MDP, gluconate, citrate, and trypsin using Na2S2O4.
    • High bone accumulation (50%) of 99mTc observed with HEDSPA and MDP labeling.
    • Two distinct 99mTc-gluconate complexes were prepared: Complex I (24% kidney uptake, Tc(V) bound) and Complex II (2.2% kidney, 15.4% bone uptake).
    • Direct complexation of technetium by chelate-forming groups, without "mixed complex" formation.

    Conclusions:

    • Na2S2O4 is an effective reducing agent for neutral pH 99mTc radiolabeling.
    • The developed methods allow for the preparation of 99mTc-labeled compounds with varying biodistribution profiles, including bone-targeting agents.
    • The study provides insights into the complexation chemistry of technetium with different ligands.